Following My Diagnosis, Negative Thoughts Consumed Me
Even before I received my official diagnosis of idiopathic pulmonary fibrosis (IPF), the thought of death consumed me. I had trouble sleeping. ... Read more
Updates
-
-
Indalo Therapeutics Starts Phase 1 Trial Testing Antifibrotic Candidate IDL-2965
Indalo Therapeutics has launched a Phase 1 clinical trial testing the company’s lead antifibrotic candidate IDL-2965 for patients with fibrotic diseases such as idiopathic ... Read more -
Despite Benefits, Many IPF Patients Switching from Esbriet to Ofev Stop Treatment, Possibly Due to Low BMI, Study Says
Many patients with idiopathic pulmonary fibrosis (IPF) who are switching from Esbriet (pirfenidone) to Ofev (nintedanib) discontinue treatment, especially if they are underweight ... Read more -
PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community
The pulmonary fibrosis (PF) community is invited to attend the Pulmonary Fibrosis Foundation‘s PFF Summit, which is the largest healthcare meeting on PF, ... Read more -
Lessons I’ve Learned Since My IPF Diagnosis 3 Years Ago
We learn the most important lessons in the most difficult times, and I’m grateful to have had opportunities to live those lessons and share ... Read more
-
Rare Gene Variants Linked to Worse Lung Transplant Outcomes in PF Patients
Rare variants in genes that regulate the end regions of chromosomes — called telomeres ... -
Finding Support While Going Through Difficult Times
Before receiving my official diagnosis of idiopathic pulmonary fibrosis (IPF), I was confident in ... -
IPF Patients Live Longer on Ofev Compared with Placebo, Analysis Suggests
Treatment with Ofev (nintedanib) can significantly extend the survival of patients with idiopathic pulmonary fibrosis ... -
Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF Research
The American Thoracic Society (ATS) Foundation and Boehringer Ingelheim have awarded a physician scientist at ... -
10 Exercise Myths and Truths: Advice from a Respiratory Specialist
Myth 1: If you can’t run with the big dogs, stay on the porch. ... -
Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces
Pliant Therapeutics has successfully completed a Phase 1 clinical study assessing its investigational therapy ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News
Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more